MedTrace Logo

The Effect of Enhanced Recovery After Surgery in Endoscopic Sinus Surgery

NCT04048070 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2019-08-13

No results posted yet for this study

Summary

Enhanced recovery after surgery (ERAS) protocols have been widely applied during perioperative periods for different diseases, there are few reports of ERAS in patients undergoing endoscopic sinus surgery (ESS). This study therefore aimed to evaluate the benefits of ERAS protocol compared to traditional care following ESS.

Conditions

  • Chronic Rhinosinusitis (Diagnosis)
  • Surgery

Interventions

DRUG

Flurbiprofen Axetil

One kind of NSAIDs, 200mg for 48 hours after surgery.

DRUG

Sufentanil

One kind of opioid drugs, 1.5μg/kg, and recorded the drug consumption after surgery

BEHAVIORAL

Extended perioperative counseling

The extended perioperative counseling contained additional information, including surgery procedures, importance of medicine treatment and medical help to relieve depression and anxiety about disease during peri-operation period.

BEHAVIORAL

Shorter fasting food and water time before surgery

The patients in ERAS group were required to fast food for 6 to 8 hours and provided 12.6% maltodextrin carbohydrate supplement beverage for 2 hours before surgery

BEHAVIORAL

Conventional perioperative counseling

THe conventional perioperative counseling included the risk of surgery and prognosis of disease and other things patients need to know.

BEHAVIORAL

Regular fasting food and water time before surgery

The stricter control of preoperative fasting requirements, prohibiting solids and liquids from previous midnight to operation time.

Sponsors & Collaborators

  • Beijing Tongren Hospital

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-03
Primary Completion
2018-10-15
Completion
2018-10-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04048070 on ClinicalTrials.gov